Naming more names.
Henchmen and henchwomen of the Oligarchs Culling Shit (TM/Sage Hana Productions)
Jordan Schachtel’s recent reporting about Dr. Terry Adirim, MD, MPH, MBA, as a medical officer within the Department of Defense instrumental in the military cull for her memo defining EUA products and Comirnaty as “interchangable,” and the marking of the 75th anniversary of the Nuremberg Code derived from the Doctors Trial — including Holocaust survivor Vera Sharav’s speech (transcript) — reminded me of that layer of culpable actors in the Department of Health and Human Services.
These men and women comprise one of the administrative tiers of the Oligarchs Culling Shit system, without whose original complicity the process could not have started, and without whose ongoing complicity it cannot continue.
They’re the Good Germans who make the trains to the concentration camps lines at the walk-in vaxx clinics run smoothly.
They’re more defendants for the federal criminal prosecutions that need to happen.
Some of the most horrific ethical abdications by researchers and physicians have occurred within the Food and Drug Administration, where Dr. Marion Gruber held signing authority for all three of the primary lethal injections EUA-authorized by teams of scientists.
Dr. Gruber’s title was Director of the Center for Biologics Evaluation and Research (CBER) Office of Vaccine Research and Review (OVRR), a position now occupied by Dr. Peter Marks, who is carrying forward Gruber’s lethal legacy.
Gruber resigned from her FDA position effective Nov. 1, 2021, and now works as Vice President for Public Health and Regulatory Science at IAVI, the International AIDS Vaccine Initiative, launched by the Rockefeller Foundation in 1994.
IAVI is funded by the Bill & Melinda Gates Foundation (BMGF), US Agency for International Development (USAID), World Bank, Coalition for Epidemic Preparedness and Innovation (CEPI), US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA), National Institutes of Health (NIH), National Institutes of Allergies and Infectious Diseases (NIAID), US Department of Defense Congressionally Directed Medical Research Program, GlaxoSmithKline, Merck and other mass-murderous, anti-human global oligarchic institutions.
From the FDA’s Covid-19 Emergency Use Authorizations page:
2020/12/11 - Pfizer/BioNTech
2020/12/18 - Moderna
2021/02/27 - Janssen
Below are the names of the product reviewers — led by Marion Gruber — whose rendered scientific opinions gave the illusion of credibility and lawfulness to the propulsion of the lethal injections out of the laboratories and manufacturing facilities, into the trucks, across the highways, into the clinics, into the hands of the nurses, doctors and pharmacists, and into the bodies of hundreds of millions of people worldwide.
Acronym key at the footnote1.
2020/12/11 - Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum - Pfizer BioNTech
Marion Gruber, Ph.D., Director, CBER/OVRR, signatory authority
Ramachandra Naik, Ph.D., Chair, OVRR/DVRPA
Capt. Michael Smith, Ph.D., Regulatory Project Manager, OVRR/DVRPA
Susan Wollersheim, M.D., Clinical reviewer, OVRR/DVRPA
Nabil Al-Humadi, Ph.D., Toxicology reviewer, OVRR/DVRPA
Lei Huang, Ph.D., Biostatistics reviewer, OBE/DB
Haruhiko Murata, Ph.D., CMC/Product reviewer, OVRR/DVP
Xiao Wang, Ph.D., CMC/Product reviewer, OVRR/DVP
Laura Fontan, Ph.D., CMC/Facility reviewer; OCBQ/DMPQ
Kathleen Jones, Ph.D., CMC/Facility reviewer, OCBQ/DMPQ
Kerry Welsh, M.D., Pharmacovigilance reviewer, OBE/DE
Narayan Nair, M.D., Pharmacovigilance reviewer, OBE/DE
Brenda Baldwin, Ph.D., Data Integrity reviewer, OVRR/DVRPA
Bhanumathi Kannan, Ph.D., BIMO reviewer, OCBQ/DIS/BMB
Oluchi Elekwachi, Ph.D., Labeling reviewer, OCBQ/DCM/APLB
2020/12/18 - Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum - Moderna
Marion Gruber, Ph.D., Director, CBER/OVRR, signatory authority
Sudhakar Agnihothram, Ph.D., Chair, OVRR/DVRPA
Goutam Sen, Ph.D., Regulatory Project Manager, OVRR/DVRPA
Rachel Zhang, M.D., Clinical reviewer, OVRR/DVRPA
Ching-Long Sun, Ph.D., Toxicology reviewer, OVRR/DVRPA
Ye Yang, Ph.D., Biostatistics reviewer, OBE/DB;
Alena Dabrazhynetskaya Ph.D., CMC/Product reviewer, OVRR/DVP
Li-Sheng Fowler Ph.D., CMC/Product reviewer, OVRR/DVP
Obinna Echeozo MPH, MBA, CMC/Facility reviewer; OCBQ/DMPQ
Ekaterina Allen Ph.D., CMC/Facility reviewer; OCBQ/DMPQ
Timothy Martin Ph.D., CMC/Facility reviewer; OCBQ/DMPQ;
Jane Baumblatt M.D., Pharmacovigilance reviewer, OBE/DE;
Daphne Stewart, Labeling reviewer, OVRR/DVRPA
Brenda Baldwin Ph.D., Data Integrity reviewer, OVRR/DVRPA
Christine Drabick M.S, BIMO reviewer, OCBQ/DIS/BMB
Oluchi Elekwachi, Pharm.D., MPH, Labeling reviewer, OCBQ/DCM/APLB
2021/02/27 - Emergency Use Authorization (EUA) for an Unapproved Product Review Memorandum - Janssen
Marion Gruber, Ph.D., Director, CBER/OVRR, signatory authority
Bharat Khurana, DVM, Ph.D., MBA, Regulatory Project Manager, OVRR/DVRPA
Sudhakar Agnihothram, Ph.D., Committee chair, OVRR/DVRPA
Rachel Zhang, M.D., Clinical reviewer, OVRR/DVRPA
Yosefa Hefter, M.D., Clinical reviewer, OVRR/DVRPA
Claudia Wrzesinski, Ph.D., Toxicology reviewer, OVRR/DVRPA
Ye Yang, Ph.D., Biostatistics reviewer, OBE/DB
Lei Huang, Ph.D., Biostatistics reviewer, OBE/DB
Marian Major, Ph.D., CMC/Product reviewer, OVRR/DVP
Alla Kachko, Ph.D., CMC/Product reviewer, OVRR/DVP
Pankaj (Pete) Amin, B.S., CMC/Facility reviewer; OCBQ/DMPQ
Holly Brevig, Ph.D., CMC/Facility reviewer; OCBQ/DMPQ
Jane Woo, M.D., Pharmacovigilance reviewer, OBE/DE
Brenda Baldwin, Ph.D., Data Integrity reviewer, OVRR/DVRPA
Haecin Chun, M.S., BIMO reviewer, OCBQ/DIS/BMB
Bhanu Kannan, M.S., BIMO reviewer, OCBQ/DIS/BMB
Oluchi Elekwachi, Pharm.D., MPH, Labeling reviewer, OCBQ/DCM/APLB
APLB - Advertising and Promotional Labeling Branch
BIMO - Bioresearch Monitoring Program
BMB -
CBER - Center for Biologics Evaluation and Research
CMC - Chemistry Manufacturing and Controls
DE -
DIS - Division of Inspections and Surveillance
DMPQ - Division of Manufacturing and Product Quality
DVP - Division of Viral Products
DVRPA - Division of Vaccines and Related Product Applications
OBE - Office of Biostatistics and Epidemiology
OCBQ - Office of Compliance and Biologics Quality
OVRR - Office of Vaccine Research and Review
There is satisfaction in knowing they will be burning in hell for all eternity.
this list needs to be spread wide and far, so that these people can be banned from clinics, restaurants, and everything imaginable, they poisoned millions of people ! they will never be condemned, but we the people can condemn them